Labcyte Closes Third Round of Venture Financing, Paving the Way for Future Growth
Labcyte Inc. of Sunnyvale, California (U.S.) is impacting health sciences through its proprietary technology for using focused ultrasound to exactly transfer droplets down to 2.5 nanoliters. Through the transfer of compounds directly into assay plates, its technology eliminates the requirement for tips, washing, and intermediate dilutions. Labcyte closed $21 million in Series C financing last month, and its list of customers includes GlaxoSmithKline and Astro Zeneca, as well as academic institutions, including Vanderbilt University.
↑ Back to Nano World Breaking News™
Nano World News™ Issue Archive:
RSS feed